Vol. 274, Issue 1, F197-F204, January 1998
Characterization of the 5'-flanking region of OK cell
type II Na-Pi cotransporter gene
Helene
Hilfiker,
Claudia M.
Hartmann,
Gerti
Stange, and
Heini
Murer
Department of Physiology, University of Zurich, CH-8057 Zurich,
Switzerland
 |
ABSTRACT |
The renal type II
Na-Pi cotransport is the
rate-limiting step in proximal tubular phosphate
(Pi) reabsorption. Among the
different "proximal tubular" cell lines, this transporter seem
only to be expressed in opossum kidney cells (OK cells). We have
isolated the 5'-flanking region of the ok-Npt2 gene (OK cell type
II Na-Pi cotransporter) including
exons 1-3 and containing a TFIID site (TATA box), a GCCAAT site,
an AP1 site, and two microsatellite GGAA repeats. Major transcription
initiation sites were determined by primer extension and rapid
amplification of 5' cDNA ends (5'-RACE). A 327-bp fragment
containing the TFIID and GCAAT element was driving the downstream
luciferase reporter gene in homologous transfection assays. Slightly
reduced promoter activity was observed with a 198-bp fragment
containing the GCAAT element; shorter fragments were without activity.
Promoter activity (327-bp fragment) could also be observed in
transfections into HeLa cells but not in U937 human macrophage cells,
MCT mouse kidney cortex cells, and MDCK cells. Different
"physiological" stimuli known to be associated with altered
proximal tubular Na-Pi cotransport
activity are without effect on transcriptional activity in above
homologous transfection experiments.
renal phosphate transporter; promoter; brush-border membrane; parathyroid hormone
 |
INTRODUCTION |
PHOSPHATE (Pi)
reabsorption in the mammalian proximal tubule is altered under a
variety of physiological and pathophysiological conditions (for review,
see Refs. 3, 6, 22). Brush-border membrane
Na-Pi cotransport was found to be
the rate-limiting and pathophysiologically altered transport step. Two
different brush-border membrane
Na-Pi cotransporters have been
identified by expression cloning techniques. Both, the type I and type
II transporters were found to be exclusively located in the proximal
tubule (for review, see Refs. 13, 19-21).
The type II Na-Pi cotransporter
was identified from different animal species (9, 11, 16, 27, 29, 30,
32), including the opossum kidney-derived OK cell line (NaPi-4, Ref.
27), the only renal cell model expressing this transporter in
significant amounts and frequently used to dissect the cellular and
regulatory mechanisms involved in regulation of proximal tubular
brush-border membrane Na-Pi
cotransport (for review, see Ref. 22). The type II
Na-Pi cotransporter is altered
under a variety of physiological and pathophysiological conditions (for
reviews, see Refs. 13, 19-21). Such regulatory phenomena were also
seen in OK cells, for example, for parathyroid hormone (PTH; 5, 17, 23a), for alterations in the medium phosphate content (4, 18, 25, 26),
for glucocorticoids (31), for thyroid hormone [triiodothyronine (T3); see Ref. 28],
and for epidermal growth hormone (1).
The gene structure for the human and murine type II
Na-Pi cotransporter gene (NPT2 and
m-Npt2) has recently been determined (8). In the present study, we
report the isolation and characterization of the 5'-flanking
region of the OK cell type II
Na-Pi cotransporter (ok-Npt2). We
demonstrate that the ok-Npt2 promoter is active in the homologous OK
cell system and hardly regulated by PTH or changes in the phosphate
concentration in the medium.
 |
MATERIALS AND METHODS |
Materials. Restriction enzymes were
obtained from Biofinex (Switzerland); DNA modifying enzymes, pGL3
luciferase reporter gene plasmids, and luciferase reporter gene assay
were from Promega (Madison, WI); pBluescript
SK+ plasmid was acquired from
Stratagene (La Jolla, CA); pCMV-LacZ was kindly provided by Dr. S. Rusconi, University of Zurich, Switzerland; pUC19
Nco I was obtained from Dr. H. Rhyner,
Children's Hospital of Zurich, Switzerland;
[
-32P]dCTP,
[
-35S]dATP, and
[
-32P]ATP were
purchased from NEN Research Products (Du Pont Canada) and
oligonucleotides were synthesized by Microsynth.
Gene isolation and mapping. Genomic
DNA from cultured OK cells (3B/2 clone) was extracted and dialyzed
according to current protocols (2). A genomic Southern blot
was hybridized with a
32P-labeled 5' end probe
(oligolabeling kit, Pharmacia) isolated from OK cell NaPi-4 cDNA (27)
in pSPORT1 (560-bp Mlu
I-Sac I, see Fig.
1) overnight at 42°C in 50% formamide
solution supplemented with 5% dextran sulfate (2). The filter was
washed twice with 2× SSC (1× SSC is 0.15 M NaCl and 0.015 M
sodium citrate, pH 7.0)-0.1% sodium dodecyl sulfate (SDS) at room
temperature and twice with 0.5× SSC-0.1% SDS at 55°C and
exposed on Kodak films with intensifying screen. A 12- to 15-kb
BamH I genomic fragment
could be detected on the genomic Southern blot. For construction of a
library, OK cell genomic DNA was digested with
BamH I and size fractionated on a
10-40% sucrose gradient. A fraction of 12-20 kb was ligated into
DASH II-BamH I (Stratagene),
and 106 plaque-forming units
were screened with the probe mentioned above. A genomic
clone of ~14 kb (
OKGL41.1, see Fig. 1) was isolated. A 6,000-bp
EcoR
I-BamH I fragment was subcloned into
pBluescript SK+ (Stratagene). The
DNA was purified in small quantities by spin columns (Qiagen).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Genomic organization of OK cell Npt2 (ok-Npt2). A genomic
BamH I clone of 14 kb ( OKGL41.1)
was isolated from a OK cell DASH II library. A 6,000-bp
EcoR
I-BamH I subfragment was cloned into
pBluescript SK+ and sequenced. It
contained exons 1 to 3 (solid boxes), introns 1 to 3 (open boxes), and
4.7 kb of 5'-flanking region. A consensus binding site for TFIID
(TATA box) at 30 and a "GCAAT" element at 124 were
identified. The 5'-flanking region as well as intron 3 of the OK
cell Npt2 gene exhibit long GGAA repeats of unknown function
(microsatellites; gray shaded boxes).
Top: the 560-bp
Mlu
I-Sac I cDNA probe used for screening
the DASH II library; the polylinker is depicted as solid black, the
5' untranslated region is shaded in gray, and the coding region
is open. Bottom: different constructs
used for the analysis of promoter function; fragments of different size
ranging from 4700 to 67 and including 54 bp of exon 1 have been cloned in front of the luciferase reporter gene of pGL3 basic
(Promega) to estimate the corresponding transcriptional
activity.
|
|
The DNA was sequenced on both strands by the dideoxynucleotide chain
termination method (Pharmacia Kit) and analyzed using the University of
Wisconsin Genetics Computer Group Software, version 8.1.
Cell culture. The opossum kidney
proximal tubule cell line (3B/2) and the human HeLa-S3 cell line were
grown in Dulbecco's modified Eagle's medium-Ham's F12 (DMEM-F12)
supplemented with 10% fetal calf serum (FCS) and 2 mM
L-glutamine. The human
macrophage cell line U937, the Madin-Darby canine kidney (MDCK) cell
line, and the mouse kidney cortex cell line MCT (10) were cultivated in
DMEM supplemented with 10% FCS. All cell cultures were kept at
37°C in a humidified environment (5%
CO2, 95% air).
ok-Npt2 promoter-luciferase constructs:
electroporation and enzyme assays. A 327-bp genomic
fragment was generated by polymerase chain reaction (PCR) on the
6,000-bp EcoR
I-BamH I subfragment of
clone
OKGL41.1 with an antisense primer localized within exon 1 (NaPi4-31/50R, see Fig. 2) and a sense
primer starting at position
327 on the ok-Npt2 gene. The
fragment was digested with Apa I (located in the 5'-flanking region of ok-Npt2), subcloned into pBluescript SK+ cut with
Apa I and
Sma I (pB327), and sequenced. To
generate the luciferase reporter gene construct pGL327, the insert was excised from pB327 by BamH I and
Kpn I (both located within the polylinker of pBluescript SK+)
and subcloned into pGL3 basic vector digested by
Kpn I and
Bgl II. Genomic DNA fragments of 140 to 208 bp were generated by PCR on pB327 (mentioned above) with a
pBluescript SK+ primer (5'
CCATGATTACGCCAAGCTC 3') and different ok-Npt2-specific sense
primers. The construct pGL208 extends from position
154, pGL206
from
152, pGL198 from
144, pGL194 from
140, pGL173
from
119, pGL168 from
114, pGL140 from
86 and
pGL121 from
67, and the whole set of PCR generated fragments end
within exon 1 at position +54. The amplified DNA was digested with
BamH I (located in the polylinker of
pBluescript SK+), subcloned into
the pGL3 basic vector digested with
Bgl II and Sma I, and sequenced on both strands.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 2.
Sequence of the 5'-flanking region of the OK cell Npt2 gene
(ok-Npt2). This 3,017-bp sequence is part of the 6,000-bp
EcoR
I-BamH I fragment (see Fig. 1), which
has been sent to the GenBank/EMBL Data Bank (6 kb of sequence;
accession no. AJ003021). The first nucleotide corresponding to
the OK cell NaPi-4 cDNA is depicted as +16, and the main transcription
start site is at +1. Exons 1-3 are underlined, and coding sequence
is in uppercase letters. Translation start site (double underlined) is
located within the second exon. A possible TFIID binding site and the
conserved GCAAT element are boxed in bold. A potential AP1 site at
304 is underlined. The two microsatellite GGAA repeats of
unknown function are in italic lowercase. The 3' end primer
(NaPi4-31/50R) used for generation of the OK cell promoter
constructs is marked in the gray shaded box.
|
|
The luciferase reporter gene constructs pGL1700 and pGL4700 were
generated by linking a 1,400-bp Sac
I-Apa I or a 4,400-bp EcoR
I-Apa I subfragment of clone
OKGL
41.1 to the 327-bp Apa I-BamH I fragment mentioned above.
For standardization of the promoter activity in different cell lines,
the pGL3 promoter (pGL3-SV40, enhancerless simian virus promoter) and
the pGL3 basic vector (Promega) were used. As internal standard, a
-galactosidase-expressing vector pCMV-LacZ was cotransfected. Transient cell transfections were performed by electroporation. Approximately 107 cells in DMEM
without FCS were electroporated at 960 µF and 250 V with 5 µg (OK
cells), 10 µg (MCT, MDCK and U937), or 20 µg (HeLa-S3) of pGL3
constructs and equal amounts of pCMV-LacZ and plated on 3.5-cm diameter
dishes. The cells were harvested 48 h after transfection in 100 µl of
1× lysis buffer (Promega). The
-galactosidase reaction was
performed in 0.1 M NaPO4, pH 7.5, 4 mg/ml
o-nitrophenyl-
-galactopyranoside, and 1 mM MgCl2 for 30 min to 4 h
at 37°C, and the optical density was measured at 420 nm. Luciferase
was assayed with a luciferase kit (Promega) and measured in a
luminometer (Lumac Biocounter M1500).
For studies related to the effect of PTH and phosphate concentration,
the electroporated cells were plated into 24-well plates in triplicate
and kept for 4 h in DMEM-F12 supplemented with 10% FCS to improve
vitality. Subsequently cultured cells were switched for 24 h to the
corresponding medium (22 mM
, 5%
CO2, and pH 7.4) without FCS. For
studies with altering phosphate concentration, cells were kept in
phosphate-free DMEM (Sigma) supplemented with 0.1, 0.9, and 1.5 mM
phosphate. To determine the hormonal effect, the cells were either
incubated in 10
8 M PTH or
in its vehicle. The cells were used for uptake studies and then
harvested in the reporter gene lysis buffer for determination of
luciferase and
-galactosidase activity. Protein concentration and
Pi uptake was performed as
described (23a).
Rapid amplification of 5' cDNA ends
(5'-RACE). For 5'-RACE OK cell total RNA
(10 µg) isolated with Trizol (GIBCO-BRL) was retrotranscribed with 20 U Moloney murine leukemia virus reverse transcriptase (MLV-RT, Promega)
using a NaPi-4 cDNA-specific (OK cell; Ref. 27) primer (nt
386-405; antisense). The product was cleaned by the GeneClean II
kit (BIO 101). The 5' end of the cDNA was extended by a
polynucleotide transferase (30 U, GIBCO-BRL) in presence of 0.4 mM
dATP. PCR was performed with a second NaPi-4 cDNA-specific primer (nt
276-291; antisense), a T17
adapter primer, and an adapter primer (7). The PCR product
was digested with Sal I (located in the adapter
primer) and Nco I (NaPi-4 cDNA) and
subcloned into pUC19 Nco and sequenced. By this method we obtained four
different extension products (see
RESULTS).
Primer extension. A quantity of 10 µg of OK cell total RNA (see above) was retrotranscribed with 20 U
MLV-RT (Promega) in presence of 80,000 cpm of a
32P-labeled 5' NaPi-4
cDNA-specific (OK cell; Ref. 27) primer (nt 45-65 or nt
50-70, both antisense). Labeling of the oligonucleotide was
performed with 8 U polynucleotide kinase (Promega) in presence of 50 µCi [
-32P]ATP.
The extension product was ethanol precipitated and loaded on a 6%
sequencing gel in presence of a sequencing ladder performed with the
primers mentioned above on genomic DNA (pGL327).
 |
RESULTS |
Structure of the OK cell type II
Na/Pi-cotransporter (Npt2)
5'-flanking region.
The organization of the ok-Npt2 promoter region was determined by
screening a genomic OK cell
DASH
BamH I library with a 560-bp
Mlu
I-Sac I fragment representing the very
5' end of the OK cell type II
Na-Pi cotransporter cDNA (see Fig.
1). A single clone
OKGL41.1 of ~14 kb was obtained, and a 6,000-bp
EcoR
I-BamH I subfragment was subcloned
into plasmid pBluescript SK and fully sequenced (see Figs. 1 and 2). It
contained in its 3' region exon 1 corresponding to nt 12-64,
exon 2 corresponding to nt 65-177, and exon 3 corresponding to nt
178-333 of the OK cell NaPi-4 cDNA (27). A comparison of the
intron/exon boundaries is presented in Table
1. In ok-Npt2, exon 2 contains only 1 base
of 5'-untranslated region, in contrast to the m-Npt2
and h-NPT2 where the translation initiation site is also on exon 2 but
further downstream (8). A high homology in the organization between
mouse, human, and opossum NPT/Npt2 genes is suggested by the identity
of encoded amino acids and coding phase usage at the intron/exon
boundaries (Table 1; introns 2 and 3).
The promoter region of the ok-Npt2 gene reveals a homology of ~56%
if compared with the first 170 bp of the murine or the human promoter
(8). Two highly conserved regions can be observed, with one
representing a classic TATA box (TFIID binding element) and the other a
GCAAT element. Both are located at a similar position within the type
II Na-Pi cotransporter promoters
(see Fig. 3). An AP1 binding site (see Fig.
2, at
304, underlined) but no classic Sp1 binding site,
glucocorticoid (GRE), T3 (TRE), or
vitamin D3 (VDRE) responsive
elements could be detected. (A quantity of 6 kb of 5'-flanking
sequence have been analyzed for ok-Npt2; GenBank/EMBL Data Bank;
accession no. AJ003021).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Sequence comparison of the 5'-flanking regions of the OK cell
(ok-), human (h-), and the murine (m-) Npt2. Comparison of the first
170 bp of the OK cell, the human, and the murine promoter including the
first exon reveal sequence homology (*) around a GCAAT element and
a conserved TFIID binding site (both boxed and underlined).
Transcription initiation sites of the ok- and m-NPT2 gene determined by
both rapid amplification of 5' cDNA ends (5'-RACE) and
primer extension are underlined. Exon 1 of the OK cell, human, and
murine type II Na-Pi cotransporter
gene is depicted in uppercase letters; +1, the major transcription
initiation site in ok-Npt2; and +16, the start of the cDNA previously
identified (27).
|
|
Transcription initiation site. To map
the transcription initiation site of the ok-Npt2 gene, both
5'-RACE and primer extension were performed. For primer
extension, two 21-mer reverse primers were tested (nt 45-65 of the
NaPi-4 cDNA, results shown in Fig. 4, and
nt 50-70, not shown). In both cases the autoradiogram of the
extended fragments showed three major transcription start sites at +1,
+2, and +5. Additional transcription initiation sites could be observed
by performing 5'-RACE on OK cell total RNA at position +4 (see
Fig. 4).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 4.
Determination of the transcription initiation site by primer extension
(arrowheads) and by 5'-RACE (asterisks), for comparison. Sequence
corresponding to the OK cell NaPi-4 cDNA (starting at +16) is given in
bold, potential transcription initiation sites as obtained by primer
extension are marked by arrows, and those obtained from sequencing
5'-RACE products are indicated by asterisks. For further details
see MATERIALS AND
METHODS.
|
|
5' Deletion analysis of the ok-Npt2 promoter in
OK cell line 3B/2. Different constructs of 5'
truncated promoter fragments containing 121 to 4700 bp and
comprising at least the TATA box and part of the untranslated exon 1 (nt 12-50 of the NaPi-4 cDNA of OK cells) were cloned in front of
the promoterless luciferase reporter gene of the pGL3-basic vector
(Promega) and designated pGL121 to pGL4700 (See Figs. 1 and 5). The
reporter gene constructs comprising 194 to 4700 bp showed
a similar luciferase activity in transiently transfected OK cells,
whereas for the shorter fragments missing the conserved GCAAT element
(see Fig. 1) the promoter activity was nearly abolished and similar to
the promoterless basic vector (see Fig. 5).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
ok-Npt2 promoter activity in the OK cell line 3B/2. Fragments of
different size ranging from 4700 to 67 and all including
54 bp of exon 1 (see Fig. 1) were subcloned into the luciferase
reporter vector pGL3 to estimate the corresponding transcriptional
activity. The fragments missing the GCAAT element, pGL121 to pGL173,
were similar to the promoterless pGL3 construct in activity
measurements. The larger fragments including the conserved GCAAT region
pGL194 to pGL4700 had activities similar to the enhancerless pGL3-SV40
promoter construct. At least 3 independent experiments were done in
triplicate.
|
|
Comparative analysis of ok-Npt2 promoter activity in
different eukaryotic cell lines. The construct pGL327,
which showed full promoter activity in OK cells (see Fig. 5), was
tested in the human cell line HeLa-S3, in the U937, the MDCK, and the
MCT cell lines (Fig. 6). The
promoter was inactive in the murine kidney cell line MCT, in the canine
kidney cell line MDCK, and in the human cell line U937. In agreement
with this observation no transcription product of an intrinsic type II
Na-Pi cotransporter could be
obtained by RT-PCR in MCT and U937 cells (data not shown); in MDCK
cells Northern hybridizations were unable to document the existence of
this transporter (data not shown). Surprisingly, in the human cell line
HeLa-S3 the ok-Npt2 promoter was active to a similar extent as in OK
cells if compared with the pGL3-SV40 promoter (Fig. 6,
A-E),
although in this cell line type II
Na-Pi cotransporter mRNA could not
be detected by RT-PCR (data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of the OK cell Npt2 promoter in different cell lines. The
promoterless luciferase constructs pGL3, the OK cell promoter construct
pGL327 (see Fig. 1), and the enhancerless SV40 promoter construct
pGL3-SV40 were electroporated in different cell lines
(A-E)
in presence of the pCMV-LacZ vector for standardization. Luciferase and
galactosidase activities were measured 48 h posttransfection. High
activity of the OK cell promoter could be observed in the homologous
system of OK cells (A) and in human
HeLa cells (B). In the human
macrophage cell line U937 (C), in
the murine kidney cell line MCT (D),
and the canine renal distal tubular cell line MDCK
(E), the OK cell promoter had only a
low activity. For each cell line data from 3 independent experiments
done in triplicate were used.
|
|
Functional analysis of the ok-Npt2
promoter. The phosphate content of the medium has been
shown to play a regulatory role on type II
Na-Pi cotransporter expression in
OK cells (4, 18, 24-26). In low-phosphate medium, the
Na-Pi cotransport activity is
upregulated. The experiments performed previously in our laboratory suggested that this effect is independent of an activation of transcription and might be related to an altered mRNA processing (4,
18). In accordance to our previous results (4, 18), the constructs
pGL327 and pGL4700 did not respond to a shift from normal DMEM-F12 to
high-phosphate (1.5 mM), normal (0.9 mM), or low-phosphate (0.1 mM)
DMEM medium for 24 h (Fig.
7B).
It should be indicated that Saxena and co-workers (25, 26) have
recently reported that with their OK cells the adaptive response in
transport and specific mRNA content was prevented by actinomycin D. We
cannot explain this apparent discrepancy in the data obtained by the
two laboratories. PTH has been shown to downregulate the activity of
the type II Na-Pi cotransporter protein in the OK cell line (5, 17, 23a). Studies on rats have shown a
small decrease in NaPi-2 mRNA content in response to acute PTH
administration (12). We have recent provided evidence that the
downregulatory effect in OK cells might be due to internalization and
subsequent degradation of the type II
Na-Pi cotransporter (23). To test
for an effect of PTH on the ok-Npt2 promoter activity, we have
transiently transfected OK cells with the ok-Npt2 luciferase reporter
gene constructs and incubated them in FCS-free DMEM-F12 supplemented
with PTH (10
8 M) for 24 h.
PTH had no downregulatory effect on the activity of the ok-Npt2
promoter in the OK cell line (Fig.
7A).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of different "stimuli" known to influence the activity of
the type II Na-Pi cotransporter.
OK cells (3B/2) were electroporated in presence of diverse pGL3
constructs. For each transfection, cells were equally plated in 24-well
plates and after 4 h switched to fetal calf serum-free medium treated
with 10 8 M parathyroid
hormone (PTH) in DMEM-F12 at 5%
CO2
(A) or with 0.1, 0.9 or 1.5 mM
phosphate DMEM medium (Sigma) at 5%
CO2
(B) for 24 h. In several experiments
the cytomegalovirus (CMV) promoter activity of the vector used for
standardization (pCMV-LacZ) was two- to threefold increased in presence
of PTH. Therefore, we did not include the -galactosidase assay for
standardization in A.
|
|
To prove that the transiently transfected cells responded to the
stimuli, phosphate uptake was measured in parallel. We could report a
25-30% decrease in phosphate uptake upon addition of PTH and a
30-50% difference in phosphate uptake between 0.1 and 1.5 mM
phosphate medium. These effects of PTH and
Pi deprivation are somewhat lower
than those previously reported (4, 17). One of the reasons for these
differences is the use of subconfluent cells (present study) instead of
confluent cells in the previous studies (4, 17).
 |
DISCUSSION |
Opossum kidney cells (OK cells) are the only renal cell line expressing
the type II Na-Pi cotransporter
(NaPi-4) in significant amounts. Furthermore, in this cell line the
transporter is regulated like in the proximal tubule (for review see
Refs. 13, 19-22). Therefore, OK cells are ideally suited in
homologous transfection studies to characterize structure and function
relationships of the type II Na-Pi
cotransport promoter.
We report the characterization of the 5'-flanking region of the
ok-Npt2 gene including the promoter region and exons 1 to 3. The first
two exons are separated by a relatively small intron of 443 bp. Within
the 5'-flanking region and adjacent to exon 3, two extended GGAA
repeats (microsatellites) of unknown function are
present. The promoter/enhancer region of the ok-Npt2 gene contains a
typical TATA box and a conserved GCAAT element, which seem to enhance
promoter activity. These motifs are also found at corresponding sites
within the published human and murine type II
Na-Pi cotransporter genes (Fig.
3). In all three species the translation start site is within the
second exon. For both the murine and the OK cell Npt2 genes, the
conserved TATA box is 31 bp away from the major transcription
initiation site (see Fig. 3). In the ok-Npt2 gene an AP1 site is
present at position
304; two AP1 sites have also been identified
in the human NPT2 gene but are located further upstream (29).
In contrast to OK cells, no promoter activity could be observed in the
human macrophage cell line U397, in the Madin Darby canine kidney MDCK
cell line of distal tubular origin, and in the murine kidney cortex
cell line MCT, and we could prove by RT-PCR and Northern blotting that
in the human, murine, and dog cell lines an intrinsic type II
Na-Pi cotransporter is absent (data not shown). These results indicate that an element might be
present within the 327-bp fragment derived from the ok-Npt2 gene that
promotes transcriptional activity in OK cells. The negative RT-PCR
result with the murine cell line MCT, a SV40 transformed cell line
derived from microdissected mice proximal tubules (10), indicates a
lack of cell differentiation. In Northern hybridizations, we could also
not observe an expression of the type II
Na-Pi cotransporter in
"proximal tubular" LLC-PK cells (17; data not shown). It remains unknown why only OK cells have retained the capacity to express the
type II Na-Pi cotransporter in
physiological relevant amounts and with the basic and regulatory
characteristics of the type II
Na-Pi cotransporter in its
proximal tubular environment.
Dietary phosphorus and PTH are important regulators of renal phosphate
reabsorption. Dietary phosphate restriction for several days leads in
rats to an increased brush-border membrane type II
Na-Pi cotransporter expression on
protein and mRNA level that cannot be prevented by actinomycin D (14,
15). Interestingly, the early effects (2 h) are independent of changes
in mRNA content. A similar phenomenon can also be observed in OK cells.
In our studies Pi deprivation led
to an increase in apical Na-Pi
cotransport activity that could not be prevented by actinomycin D (4). Similar to the rat studies, Pi
deprivation of OK cells (clone 3B/2) led at early time points to
transport alterations not paralleled by alteration in mRNA content
(18). Under chronic conditions (24 h),
Pi deprivation of OK cells led to
an increased apical expression of
Na-Pi cotransport activity that
was not always paralleled by an increase in mRNA content (Ref. 18; M. Custer and J. Biber, unpublished observations). These data suggest that
Pi deprivation (in the diet or
medium) leads to an altered Na-Pi
cotransport activity that can occur independent of an increased
transcription rate. The data obtained from the reporter gene studies
with the ok-Npt2 promoter in the "responsive" OK cell environment
are in direct support of the interpretations mentioned above.
For PTH we could recently show that inhibition of rat proximal tubular
Na-Pi cotransport is related to a
withdrawal of the protein from the apical surface; also, the mRNA level
was found to be reduced after PTH administration (2 h) to
parathyroidectomized rats (12). Similar results were obtained in the OK
cell system, where PTH treatment leads in short-term experiments to a
rapid internalization of the Na-Pi
cotransporter protein from the apical membrane (23). The present
reporter gene studies were not able to detect a change in type II
Na-Pi cotransporter promoter
activity after prolonged PTH treatment (24 h).
We have also performed reporter gene studies with additional hormones
known to regulate the type II
Na-Pi cotransporter in OK cells.
Experiments were performed for 24 h with dexamethasone (10
6 M, see Ref. 31),
T3
(10
7 M, see Ref. 28), with
insulin-like growth factor I
(10
7 M), and with epidermal
growth factor (10
8 M, see
Ref. 1). For all these conditions, we could not document reproducible and significant changes in transcriptional activity (data
not shown). In contrast to our previous studies (~50% increase, see
Ref. 28), we were unable to observe a
T3-induced increase in specific
mRNA content (data not shown). Although we have no satisfactory
explanation for this apparent discrepancy, we must conclude that
T3 effects on promoter activity
seem to be rather small and that present experimental conditions (e.g.,
cell passage number and source of FCS in culture medium) might have
prevented detection of small alterations in promoter
activity and specific mRNA-content.
The present results indicate that the ok-Npt2 promoter is
"constitutively" active and contains elements required for
cell-specific expression. We were unable to document large changes in
promoter activity for different modulators of the type II
Na-Pi cotransporter in renal cells
(proximal tubule and OK cells), indicating that the protein abundance
might be regulated predominantly at the posttranscriptional level.
 |
ACKNOWLEDGEMENTS |
We thank Dr. R. Wuethrich for supplying us with various kidney cell
lines, Dr. R. Wenger, Dr. J. Biber, and Dr. F. Verrey for helpful
discussions, and C. Gasser for preparing the figures.
 |
FOOTNOTES |
The nucleotide sequence reported in this study has been submitted to
the GenBank/EMBL Data Bank with accession no. AJ003021.
This work was supported by a Swiss National Science Foundation Grants
32.30785 and 31.46523 (to H. Murer).
Address for reprint requests: H. Hilfiker, Institute of Physiology,
Univ. of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Received 12 May 1997; accepted in final form 18 September 1997.
 |
REFERENCES |
1.
Arar, M.,
M. Baum,
J. Biber,
H. Murer,
and
M. Levi.
Epidermal growth factor inhibits Na-Pi cotransport and mRNA in OK cells.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F309-F314,
1995[Abstract/Free Full Text].
2.
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith,
and
K. Struhl.
Current Protocols in Molecular Biology. New York: Wiley, 1995.
3.
Berndt, T. J.,
and
F. G. Knox.
Renal regulation of phosphate excretion.
In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin,
and G. Giebisch. New York: Raven, 1992, p. 2511-2532.
4.
Biber, J.,
J. Forgo,
and
H. Murer.
Modulation of Na+-Pi cotransport in opossum kidney cells by extracellular phosphate.
Am. J. Physiol.
255 (Cell Physiol. 24):
C155-C161,
1988[Abstract/Free Full Text].
5.
Caverzasio, J.,
R. Rizzoli,
and
J. P. Bonjour.
Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line.
J. Biol. Chem.
261:
3233-3237,
1986[Abstract/Free Full Text].
6.
Dennis, V. W.
Phosphate homeostasis.
In: Handbook of Physiology. Renal Physiology. Bethesda, MD: Am. Physiol. Soc., 1992, sect. 8, vol. 2, chapt. 37, p. 1785-1815.
7.
Frohman, M. A.
PCR Protocols: A Guide to Methods and Applications, edited by M. A. Innes,
D. H. Gelfand,
J. J. Sninsky,
and T. J. White. New York: Academic, 1990, p. 28-38.
8.
Hartmann, C. M.,
A. S. Hewson,
C. H. Kos,
H. Hilfiker,
Y. Soumounou,
H. Murer,
and
H. S. Tenenhouse.
Structure of murine and human renal type II Na+-phosphate cotransporter genes (Npt2 and NPT2).
Proc. Natl. Acad. Sci. USA
93:
7409-7414,
1996[Abstract/Free Full Text].
9.
Hartmann, C. M.,
C. A Wagner,
A. E. Busch,
D. Markovich,
J. Biber,
F. Lang,
and
H. Murer.
Transport characteristics of a murine renal Na/Pi cotransporter.
Pflügers Arch.
430:
830-836,
1995[Medline].
10.
Haverty, T. P.,
C. J. Kelly,
W. H. Hines,
P. S. Amenta,
M. Watanabe,
R. A. Harper,
N. A. Kefalides,
and
E. G. Neilson.
Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis.
J. Cell Biol.
107:
1359-1368,
1988[Abstract/Free Full Text].
11.
Helps, C.,
H. Murer,
and
J. McGivan.
Cloning, sequence analysis and expression of the cDNA encoding a sodium-dependent phosphate transporter from the bovine renal epithelial cell line NBL.
Pflügers Arch.
228:
927-930,
1995.
12.
Kempson, S. A.,
M. Lotscher,
B. Kaissling,
J. Biber,
H. Murer,
and
M. Levi.
Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F784-F791,
1995[Abstract/Free Full Text].
13.
Levi, M.,
S. A. Kempson,
M. Lotscher,
J. Biber,
and
H. Murer.
Molecular regulation of renal phosphate transport.
J. Membr. Biol.
154:
1-9,
1996[Medline].
14.
Levi, M.,
M. Lotscher,
V. Sorribas,
M. Custer,
M. Arar,
B. Kaissling,
H. Murer,
and
J. Biber.
Cellular mechanisms of acute and chronic adaptation of rat renal Pi transporter to alterations in dietary Pi.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F900-F908,
1994[Abstract/Free Full Text].
15.
Lotscher, M.,
B. Kaissling,
J. Biber,
H. Murer,
and
M. Levi.
Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content.
J. Clin. Invest.
99:
1302-1312,
1997[Medline].
16.
Magagnin, S.,
A. Werner,
D. Markovich,
V. Sorribas,
G. Stange,
J. Biber,
and
H. Murer.
Expression cloning of human and rat renal cortex Na/Pi cotransport.
Proc. Natl. Acad. Sci. USA
90:
5979-5983,
1993[Abstract/Free Full Text].
17.
Malmström, K.,
and
H. Murer.
Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12.P3 cells.
Am. J. Physiol.
251 (Cell Physiol. 20):
C23-C31,
1986[Abstract/Free Full Text].
18.
Markovich, D.,
T. Verri,
V. Sorribas,
J. Forgo,
J. Biber,
and
H. Murer.
Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability.
Pflügers Arch.
430:
459-463,
1995[Medline].
19.
Murer, H.,
and
J. Biber.
A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation.
Pflügers Arch.
433:
379-389,
1997[Medline].
20.
Murer, H.,
and
J. Biber.
Molecular mechanisms of renal apical Na/phosphate cotransport.
Annu. Rev. Physiol.
58:
607-618,
1996[Medline].
21.
Murer, H.,
and
J. Biber.
Renal sodium-phosphate cotransport.
Curr. Opin. Nephrol. Hypertens.
3:
504-510,
1994[Medline].
22.
Murer, H.,
and
J. Biber.
Renal tubular phosphate transport: cellular mechanisms.
In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin,
and G. Giebisch. New York: Raven, 1992, p. 481-509.
23.
Pfister, M. F.,
E. Lederer,
J. Forgo,
U. Ziegler,
M. Lotscher,
E. S. Quabius,
J. Biber,
and
H. Murer.
Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters.
J. Biol. Chem.
272:
20125-20130,
1997[Abstract/Free Full Text].
23a.
Quamme, G.,
S. Pelech,
J. Biber,
and
H. Murer.
Abnormalities of parathyroid hormone-mediated signal transduction mechanisms in opossum kidney cells.
Biochim. Biophys. Acta
1223:
107-116,
1994[Medline].
24.
Reshkin, S. J.,
J. Forgo,
and
H. Murer.
Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport.
Pflügers Arch.
416:
624-631,
1990[Medline].
25.
Saxena, S.,
and
M. Allon.
The role of cytosolic calcium in chronic adaptation to phosphate depletion in opossum kidney cells.
J. Biol. Chem.
271:
3902-3906,
1996[Abstract/Free Full Text].
26.
Saxena, S.,
L. Dansby,
and
M. Allon.
Adaptation to phosphate depletion in opossum kidney cells.
Biochem. Biophys. Res. Commun.
216:
141-147,
1995[Medline].
27.
Sorribas, V.,
D. Markovich,
G. Hayes,
G. Stange,
J. Forgo,
J. Biber,
and
H. Murer.
Cloning of a Na/Pi cotransporter from opossum kidney cells.
J. Biol. Chem.
269:
6615-6621,
1994[Abstract/Free Full Text].
28.
Sorribas, V.,
D. Markovich,
T. Verri,
J. Biber,
and
H. Murer.
Thyroid hormone stimulation of Na/Pi-cotransport in opossum kidney cells.
Pflügers Arch.
431:
266-271,
1995[Medline].
29.
Taketani, Y.,
K.-I. Miyamoto,
K. Katai,
M. Chikamori,
S. Tatsumi,
H. Segawa,
H. Yamamoto,
K. Morita,
and
E. Takeda.
Gene structure and functional analysis of the human Na+/phosphate co-transporter.
Biochem. J.
324:
927-934,
1997.
30.
Verri, T.,
D. Markovich,
C. Perego,
F. Norbis,
G. Stange,
V. Sorribas,
J. Biber,
and
H. Murer.
Cloning of a rabbit renal Na-Pi cotransporter, which is regulated by dietary phosphate.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F626-F633,
1995[Abstract/Free Full Text].
31.
Vrtovsnik, F.,
M. Jourdain,
G. Cherqui,
J. Lefebvre,
and
G. Friedlander.
Glucocorticoid inhibition of Na-Pi cotransport in renal epithelial cells is mediated by protein kinase C.
J. Biol. Chem.
269:
8872-8877,
1994[Abstract/Free Full Text].
32.
Werner, A.,
H. Murer,
and
R. K. H. Kinne.
Cloning and expression of a renal Na-Pi cotransport system from flounder.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F311-F317,
1994[Abstract/Free Full Text].
AJP Renal Physiol 274(1):F197-F204
0363-6127/98 $5.00
Copyright © 1998 the American Physiological Society